Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

NCT04308330 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Ewing Sarcoma
Rhabdomyosarcoma
Wilms Tumor
Neuroblastoma
Hepatoblastoma
Germ Cell Tumor

Interventions

DRUG: Vorinostat

Sponsor

New York Medical College